In light of recurrent outbreaks of circulating vaccine-derived poliovirus 2 (cVDPV2) in Nigeria, we describe the genome sequence of a coxsackievirus A20 strain (CVA20). The nonstructural region (NSR) of this CVA20 genome showed that the enigmatic NSRs in recombinant cVDPV2s (GenBank accession numbers JX275140 and KX162716) found in Nigeria were from indigenous enterovirus species Cs (EV-Cs).
Picornavirales. The genus has 15 species, and poliovirus (the best characterized member of the genus) belongs to species C. Several coxsackie A viruses (e.g., CVA20) and some numbered EVs are nonpolio enterovirus members of species C (NPEV-C).
In 2016, we detected a CVA20 strain from a child with acute flaccid paralysis (AFP) in Nigeria (1) . The virus produced cytopathic effect (CPE) on the initial inoculation of stool suspension from the child into the L20B cell line, but the CPE was not reproducible on passage into the L20B and RD cell lines. The agent causing the irreproducible CPE was typed as CVA20 using reverse transcription-PCR amplification of part of the VP1 gene and Sanger sequencing (1) . In this study, the L20B supernatant was passaged into the HEp 2C cell line, incubated at 37°C, and observed for CPE daily using an inverted microscope. The CPE developed in the HEp 2C cell line after 7 days of incubation and was reproducible in the HEp 2C cell line. Viral RNA was extracted from the isolate using a total RNA extraction kit (Jena Bioscience, Jena, Germany), and complementary DNA (cDNA) was subsequently generated by using random hexamers with the Script cDNA synthesis kit (Jena Bioscience) as recommended by the manufacturer.
The genome of the isolate was amplified in overlapping fragments (2 to 3 kb each) as previously described (2) . The amplicons generated were pooled and shipped to a commercial facility (MR, TX, USA), where library preparation and NextGen sequencing was done. Paired-end sequencing was performed (2 ϫ 150 bp) for 300 cycles using the HiSeq system (Illumina). Assembly was completed using Kiki v0.0.9 and MEGAHIT v2.3.0 on the KBase platform (3) and the enterovirus genotyping tool (EGT) (4) with default settings. Analysis for similarity and recombination was done using SimPlot v3.5 (5) with default settings.
The genome for CVA20 strain NGR_2016 (GenBank accession number MH785183), with 7,091 nucleotides (nucleotides 289 to 7381 relative to the poliovirus reference sequence, GenBank accession number NC_002058), was assembled from 865,833 (24.4%) of the 3,548,364 reads generated. The genome has a GϩC content of 45% and encodes two proteins (65 and 2,208 amino acids) in overlapping open reading frames (ORFs) (6) . The isolate was confirmed as CVA20 by the EGT (4) (data not shown). Phylogenetic analysis and a BLAST search further confirmed the isolate as CVA20 and also showed that the P2 and P3 nonstructural regions of the virus were most similar to those of strains NIE0811456 (GenBank accession number JX275140) (87.09%) and NIE1519325 (GenBank accession number KX162716) (86.70%). NIE0811456 and NIE1519325 are recombinant circulating vaccine-derived poliovirus 2 strains (cVDPV2s) with a nonstructural region of unknown origin recovered in Nigeria in 2008 (7) and 2015 (8) , respectively. SimPlot analysis confirmed that CVA20 strain NGR_2016 was most similar to strains NIE0811456 and NIE1519325 in the P2 and 5= third of the P3 nonstructural region of the genome, respectively (Fig. 1) . It also showed that the enigmatic 5= untranslated region (UTR) of NIE0811456 (7) was very similar to that of NGR_2016 ( Fig. 1B) . Therefore, our findings show that NPEV-Cs circulating in the country were the source of a significant portion of the enigmatic regions of both recombinant cVDPV2s (NIE0811456 and NIE1519325). Data availability. The genome described here has been deposited in GenBank under the accession number MH785183. The raw reads have also been deposited in the SRA with the BioProject accession number PRJNA554498.
